Dolophine

Dolophine is the brand name for methadone hydrochloride, a synthetic opioid analgesic used in clinical practice for the long-term management of pain and as part of opioid use disorder (OUD) treatment protocols when indicated. Methadone binds to mu-opioid receptors in the central nervous system to alter perception and response to pain and to stabilize patients with chronic opioid dependence.

Key Benefits & Clinical Uses:

• Chronic Pain Management: Effective for moderate to severe pain requiring around-the-clock opioid therapy when other analgesics are inadequate.

• Opioid Use Disorder (Maintenance & Detox): Used as a long-acting maintenance therapy and detoxification agent in structured treatment programs.

• Flexible Formulations: Available in oral tablets, oral solution/syrup, and other formulations under various brand names, enabling tailored dosing.

Mechanism of Action:
Methadone is a mu-opioid receptor agonist that suppresses pain signals in the central nervous system and reduces symptoms of opioid withdrawal by producing a long-lasting opioid effect with a slower onset. It also has modest NMDA receptor antagonist properties that may contribute to analgesia.

Typical Dosage Forms:

• Dolophine (methadone) tablets: typically 5 mg, 10 mg strengths (brand/discontinued status varies by region).

• Methadone oral solution/syrup: available in multiple concentrations (e.g., 5 mg/5 mL, 10 mg/5 mL).

Administration & Dosing:

• Prescription Only: Dolophine must be prescribed and supervised by a qualified clinician.

• Pain: Initial dosing may start at a low level with gradual adjustments due to long and variable half-life.

• OUD: Typically administered once daily as part of a certified opioid treatment program under regulatory guidelines for addiction management.

Safety & Precautions:

• Controlled Substance: Methadone is a Schedule II opioid with high potential for dependence, abuse, and overdose.

• Respiratory Depression: The most serious risk; monitoring is essential, especially during initiation and dose changes.

• Cardiac Risks: May cause QT interval prolongation and serious arrhythmias (Torsades de Pointes) at high doses or with interactions.

• Interactions: Avoid concurrent use with other CNS depressants without medical oversight.

• Contraindications: Acute respiratory depression, severe asthma without resuscitative equipment, paralytic ileus, known hypersensitivity.

Common Side Effects:

• Nausea, dizziness, sedation, sweating, constipation, headache

• Serious effects include respiratory depression, hypotension, cardiac arrhythmias at higher or inappropriate doses.

Storage:

• Store at room temperature, protected from light and moisture.

• Secure storage and handling in compliance with controlled-substance regulations.